Medline Industries Recalls Reprocessed Webster CS Catheters Due to Potential Residual Material
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a Class I recall for 228 reprocessed Webster CS Catheters that may contain residual material particles, posing a risk of embolism or infection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 25, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP has initiated a voluntary Class I recall of specific lots of Medline ReNewal Reprocessed Webster CS Catheters. The recall was triggered by the discovery that these reprocessed devices may contain small particles of residual material. The FDA has classified this as a Class I recall, indicating that the use of these devices could cause serious adverse health consequences or death.
Which Products Are Affected
A total of 228 units distributed nationwide in the United States are affected. The recall includes the following models and lot numbers (EP250429 and EP250808 for all listed):
- Webster CS Catheter 10 Electrodes 2-8-2mm Spacing w/AutoID w/ EZ Steer: Model BD710DF282CRH (UDI-DI 10197344044023)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/ EZ Steer: Model BD710DF282RRH (UDI-DI 10197344044030)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/ EZ Steer: Model BD710FJ282RRH (UDI-DI 10197344044054)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/AutoID w/ EZ Steer: Model BD710FJ282CRH (UDI-DI case 40197344044048; ea 10197344044047)
What You Should Do
Medline Industries notified affected customers via letter starting December 22, 2025. Healthcare facilities and providers should immediately identify and quarantine any affected catheters from the specified lots. Facilities should follow the instructions provided in the firm's notification letter for the return or disposal of the products. For further information, facilities can contact Medline Industries, LP directly at their Northfield, IL headquarters.
Why This Matters
The use of catheters containing residual material poses significant health risks, including inflammatory responses, systemic infections, or thrombus reactions. These conditions may lead to life-threatening complications such as cerebral embolism, pulmonary embolism, or deep vein thrombosis.
Source
Information provided by the FDA under recall number Z-1319-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category